Immunocytochemical study of the action of cis-dichlorodiamino platinum on the human metaphase chromosome
- PMID: 11596509
Immunocytochemical study of the action of cis-dichlorodiamino platinum on the human metaphase chromosome
Abstract
The reaction of cis-dichlorodiamino platinum (cis-Pt) with the human metaphase chromosome was studied using both Giemsa staining and the action of anti-cis-Pt antibody. Two kinds of experiment were performed: (1) cis-Pt was placed in contact with cells in culture (in vivo tests), (2) cis-Pt was placed in contact with chromosomes fixed on slides (in vitro tests). In vivo, the presence of cis-Pt during phase G1 of the cell cycle is important for the reaction; in vitro, competition between cis-Pt and Giemsa for fixation on chromosomal DNA was shown to occur.
Similar articles
-
Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro.Acta Pol Pharm. 2004 Jan-Feb;61(1):39-44. Acta Pol Pharm. 2004. PMID: 15259856
-
Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.J Inorg Biochem. 2009 May;103(5):791-6. doi: 10.1016/j.jinorgbio.2009.02.005. Epub 2009 Feb 27. J Inorg Biochem. 2009. PMID: 19303143
-
Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.Chem Biol Interact. 2004 Jun 30;148(1-2):37-48. doi: 10.1016/j.cbi.2004.04.002. Chem Biol Interact. 2004. PMID: 15223355
-
Synthesis, cytotoxicity, cell uptake and DNA interstrand cross-linking of 4,4'-dipyrazolylmethane-linked multinuclear platinum anti-cancer complexes.Anticancer Drug Des. 2001 Apr-Jun;16(2-3):91-8. Anticancer Drug Des. 2001. PMID: 11962517
-
[Characterization of DNA-protein cross-links forming under the influence of cis-DDP].Postepy Hig Med Dosw. 2001;55(2):275-86. Postepy Hig Med Dosw. 2001. PMID: 11468974 Review. Polish.
Cited by
-
Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.Cancer Chemother Pharmacol. 1991;28(3):185-91. doi: 10.1007/BF00685507. Cancer Chemother Pharmacol. 1991. PMID: 1855275